Understanding disproportionately high cardiometabolic risk in Australians treated for psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 10, 2012, Pages 919-920

  Mitchell, Alex J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ABDOMINAL OBESITY; ADVERSE OUTCOME; AUSTRALIA; BIPOLAR DISORDER; BLOOD SAMPLING; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; COMORBIDITY; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; METABOLIC SYNDROME X; NOTE; PERIODIC MEDICAL EXAMINATION; PHYSICAL ACTIVITY; PSYCHOSIS; SCHIZOPHRENIA; SMOKING;

AUSTRALIA; HUMANS; METABOLIC SYNDROME X; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 84873617005     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412459090     Document Type: Note

References (15)

1. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes (Consensus Statement). Diabetes Care ; 2004 ; 2004. 596.
2. Bernardo M, Cañas F, Banegas JR, et al. Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area. European Psychiatry. 2009 ; 24: 431-441
3. Correll CU, Harris JL, Pantaleon Moya RA, et al. Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities. Schizophrenia Research. 2007 ; 92: 103-107 (Pubitemid 46561219)
4. Galletly CA, Foley DL, Waterreus A, et al. Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry. 2012 ; 46: 753-761
5. Jin H, Meyer JM, Jeste DV. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophrenia Research. 2004 ; 7: 195-212 (Pubitemid 39330499)
6. Kato MM, Currier MB, Gomez CM, et al. Prevalence of metabolic syndrome in Hispanic and non-Hispanic patients with schizophrenia. The Primary Care Companion to the Journal of Clinical Psychiatry. 2004 ; 6: 74-77
7. Li M, McCulloch B, McDermott R. Metabolic syndrome and incident coronary heart disease in Australian indigenous populations. Obesity (Silver Spring). 2012 ; 20: 1308-1312
8. Lin CC, Bai YM, Wang YC, et al. Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics. Journal of Clinical Psychopharmacology. 2009 ; 29: 529-536
9. Mitchell AJ, Vancampfort D, Sweers K, et al. Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders -A Systematic Review and Meta-Analysis. Schizophrenia Bulletin. 2011 ;:
10. Mitchell AJ, Vancampfort D, De Herdt, et al. Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? - A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients. Schizophrenia Bulletin. 2012a ;:
11. Mitchell AJ, Delaffon V, Vancampfort D, et al. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychological Medicine. 2012b ; 42: 125-147
12. Saddichha S, Ameen S, Akhtar S. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Journal of Clinical Psychopharmacology. 2008 ; 28: 27-31
13. Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. The Lancet. 2012 ; 379: 2279-2290
14. Vancampfort D, Vansteelandt K, Correll CU, et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators. American Journal of Psychiatry. 2012 ;:
15. Wang Z, Hoy WE, Si D. Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort study. BMC Public Health. 2010 ; 10: 487